Ensuring Patient Access to Regenerative and Advanced Therapies in Managed Care: How Do We Get There?

The Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute announced the joint release of their recent study of medical director perspectives on value demonstration and reimbursement for regenerative and advanced therapies. The study, identifies various challenges and posits possible solutions to ensure the appropriate integration of these high-value therapies into the current U.S. health care system. The study also takes a look at various proposed alternative payment and financing models to enable sustainable patient access to these products.

READ: Ensuring Patient Access to Regenerative and Advanced Therapies in Managed Care: How Do We Get There?